Atrial Fibrillation Sufferers, Warfarin Users Face Higher Dementia Risk

Atrial Fibrillation Sufferers, Warfarin Users Face Higher Dementia Risk

A new study suggests that those that suffer from the heart rhythm problem that is atrial fibrillation face a higher risk of dementia and it may be increased if the popular blood thinner and clot-preventing drug warfarin may make the risk even higher if not at optimal treatment levels.

Play Quizzes 4

Dementia – Warfarin levels are the key, not warfarin itself

Whether warfarin levels are too high or too low, it appears that you run a greater risk of dementia.

“If people’s levels of warfarin were erratic, their dementia risk was higher, whether they had AF or not,” said Dr. Jared Bunch who was the lead researcher of the story and presented his findings yesterday at the Heart Rhythm Society’s annual meeting, in San Francisco.

How Value Investors Can Win With Tech And “Fallen” Growth Stocks

Valuation Present ValueMany value investors have given up on their strategy over the last 15 years amid concerns that value investing no longer worked. However, some made small adjustments to their strategy but remained value investors to the core. Now all of the value investors who held fast to their investment philosophy are being rewarded as value Read More

Bunch was quick to point out that his paper is by no means proof that warfarin use or atrial fibrillation (AF) increases the risk of dementia, but does believe they both do, indeed, contribute to dementia due to erratic blood flow to the brain.

It’s estimated that around 2.7 million people suffer from AF and there are 20 million people presently taking warfarin so this study of over 10,000 long-term warfarin users is quite significant.

After combing the data of the 10,000, a follow up was done after seven years and found that the dementia rates in those taking warfarin for AF was much higher than those taking the drug for other conditions; 5.8 percent compared with 1.6 percent, respectively.

Bunch and a team of researchers conducted the study at Intermountain Medical Center Heart Institute in Salt Lake City, UT.

“Our study results are the first to show that there are significant cognitive risk factors for patients treated with Warfarin over a long period of time regardless of the indication for anticoagulation,”says Bunch.

Warfarin is a tricky drug to take, prescribe

Bunch explains that warfarin (Coumadin) is a tough balance, the body needs enough to eliminate clotting but if too much is taken, internal bleeding is a genuine issue and a “therapeutic range” is a must, but also difficult.

And that’s the kicker, for patients and doctors alike. Bunch found that warfarin takers in the aforementioned therapeutic range over 75% of the time, didn’t have nearly the risk of dementia that were outside of this range.

“If you’re doing well on warfarin, there’s no reason to worry,” said Bunch dissociating his study from warfarin bashing.

“But if you’re someone whose warfarin doses have to be changed a lot,” Bunch said, “you could ask your doctor about alternatives.”

Those alternatives include newer anticoagulants dabigatran (Pradaxa), rivaroxaban (Xarelto) and apixaban (Eliquis) and Bunch pointed out that each of these three is easier to prescribe than warfarin. Before any suggestions of impropriety are made against Bunch it should be noted that no monies funded the study from outside of the Institute and certainly none from the makers of the drugs mentioned.

The study shows a genuine association for a healthy level of warfarin goes a long ways. At the end of the day, patients can do themselves a tremendous favor according to Bunch by eating well, certainly not smoking or drinking to excess and getting enough exercise. While warfarin works it’s quite important to mitigate other behaviors that lead to and increased risk of heart disease and specifically atrial fibrillation.

Updated on

While studying economics, Brendan found himself comfortably falling down the rabbit hole of restaurant work, ultimately opening a consulting business and working as a private wine buyer. On a whim, he moved to China, and in his first week following a triumphant pub quiz victory, he found himself bleeding on the floor based on his arrogance. The same man who put him there offered him a job lecturing for the University of Wales in various sister universities throughout the Middle Kingdom. While primarily lecturing in descriptive and comparative statistics, Brendan simultaneously earned an Msc in Banking and International Finance from the University of Wales-Bangor. He's presently doing something he hates, respecting French people. Well, two, his wife and her mother in the lovely town of Antigua, Guatemala. <i>To contact Brendan or give him an exclusive, please contact him at</i>
Previous article Sohn Conference Winner – Short Dexcom (DXCM) Slides
Next article New Technology To Use Your Skin As A Touchscreen For Smartwatches

No posts to display